A multicenter phase 1/2 trial of lenalidomide and dose-adjusted EPOCH-R in MYC-associated DLBCL
一项多中心 I/II 期临床试验，研究来那度胺联合剂量调整的 EPOCH-R 方案治疗 MYC 相关弥漫性大 B 细胞淋巴瘤的疗效。
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2025017092
Cahill, Kirk; Godfrey, James; Nabhan, Chadi; Kline, Justin; Riedell, Peter A; Cohen, Kenneth S; Narula, Sunil; Karrison, Theodore G; Robertson, Jessica; Karmali, Reem; Venugopal, Parameswaran; Kim, Seo-Hyun; Rapoport, Aaron P; Lee, Seung Tae; Law, Jennie; Fishkin, Paul A S; Isufi, Iris; Velasco, Mario; Kaminer, Lynne; Smith, Sonali M
